XML 75 R67.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting - Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Research and development:    
Clinical development $ 4,834 $ 1,245
Employee-related 4,118 2,152
Facility and equipment costs 347 378
Pre-clinical research 26 117
Other research and development segment expenses 515 124
Total research and development 9,840 4,016
General and administrative:    
Employee-related 2,366 1,716
Professional and consulting fees 2,049 1,803
Commercial readiness 1,338 131
Other general and administrative segment expenses [1] 691 464
Total general and administrative 6,444 4,114
Total operating expenses 16,284 8,130
Loss from operations (16,284) (8,130)
Grant income 22  
Interest income 1,322 934
Interest expense (1,564) (306)
Change in fair value of warrant liabilities 7,643 14,881
Net income (loss) and comprehensive income (loss) $ (8,861) $ 7,379
[1] Other general and administrative segment expenses primarily consist of insurance, recruiting, occupancy, and information technology costs.